Solid Tumors

Latest News

FDA Updates: Assays Used in Cancer Care Get Green Light
FDA Updates: Assays Used in Cancer Care Get Green Light

August 9th 2020

Adaptive Biotechnologies’ clonoSEQ gets third approval; FDA also acts on first at-home treatment for spinal muscular atrophy.

Keytruda Approved for Early Treatment of Colorectal Cancer in Patients With Genetic Mutations
Keytruda Approved for Early Treatment of Colorectal Cancer in Patients With Genetic Mutations

June 30th 2020

Rising drug costs
Payers Should Take Action on Rising NSCLC Costs

November 29th 2019

Cancer patient
Chemotherapy Remains Significant for Cancer Treatment

November 29th 2019

TCells Attacking
Personalized Treatments Could Increase Value of Cancer Care

November 25th 2019

Latest CME Events & Activities

Tumor Board: Expert Insights on Managing Classical 𝘌𝘎𝘍𝘙 Mutations, 𝘌𝘎𝘍𝘙 Exon 20 Insertions, and Atypical 𝘌𝘎𝘍𝘙 Mutations in Metastatic NSCLC

View More

Medical Crossfire®: Expert Perspectives on Targeting c-Met Overexpression and 𝘔𝘌𝘛 Genomic Alterations in NSCLC – Unveiling the Complexities of 𝘔𝘌𝘛 Dysregulation

View More

PER Tumor Board®: Applying Recent Advances to Transform the Treatment Paradigm in SCLC—Expert Perspectives on New Approvals and Emerging Strategies

View More

Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care

View More

26th Annual International Lung Cancer Congress®

July 25-26, 2025

Register Now!

20th Annual New York Lung Cancers Symposium®

November 15, 2025

Register Now!

Cases & Conversations™: Integrating Novel Approaches to Treatment in First-line ALK+ mNSCLC – Enhancing Patient Outcomes with Real World Multidisciplinary Strategies

View More

2nd Annual Hawaii Cancer Conference

January 24-25, 2026

Register Now!

A Breath of Strength: Managing Cancer Associated LEMS and Lung Cancer as One

View More

Striking the Right Nerve: Managing Cancer Associated LEMS in Lung Cancer Patients

View More

Virtual Testing Board: Digging Deeper on Your Testing Reports to Elevate Patient Outcomes in Advanced Non–Small Cell Lung Cancer

View More

More News

© 2025 MJH Life Sciences

All rights reserved.